Rocket Pharmaceuticals, Inc.
RCKT
$2.88
-$0.05-1.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -258.03M | -258.75M | -258.08M | -253.26M | -249.31M |
| Total Depreciation and Amortization | 10.11M | 9.38M | 8.95M | 8.32M | 7.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.49M | 38.84M | 33.59M | 33.13M | 31.80M |
| Change in Net Operating Assets | 772.00K | 808.00K | 23.42M | 14.65M | 15.63M |
| Cash from Operations | -208.66M | -209.72M | -192.12M | -197.17M | -194.21M |
| Capital Expenditure | -4.19M | -5.86M | -10.20M | -13.27M | -15.46M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.83M | 137.57M | 38.97M | 11.37M | -10.86M |
| Cash from Investing | 38.64M | 131.71M | 28.77M | -1.89M | -26.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 184.56M | 185.74M | 3.28M | 192.59M | 191.24M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 184.56M | 185.74M | 3.28M | 192.59M | 191.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.53M | 107.72M | -160.07M | -6.47M | -29.28M |